Keratoconus is a progressive eye condition that affects the shape and clarity of the cornea, often beginning in the teenage ...
Two surgical procedures have been described for ICRS implantation: the mechanical method and the femtolaser method. The use of femtolaser for ICRS tunnel creation was widely accepted after FDA ...
Please provide your email address to receive an email when new articles are posted on . Corneal tissue addition keratoplasty, or CTAK, is a novel intrastromal lamellar keratoplasty technique for the ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy. This marks ...
Please provide your email address to receive an email when new articles are posted on . Two interesting innovations are corneal allogenic intrastromal ring segment implantation and corneal tissue ...
A progressive eye condition, Keratoconus, is increasingly affecting young adults due to digital lifestyles. This disorder thins and bulges the cornea, causing blurred vision. Early detection through ...
On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...
Keratoconus, a progressive eye disorder that distorts vision, is increasingly being detected among Sri Lankans, including ...
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems Inc. (“iVeena”), a clinical stage biopharmaceutical company with developmental products in keratoconus and pediatric myopia, has entered into a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback